553-21-9木香烃内酯

0.00 0.00

商品编号:

库存现货:

顾客评分:
(已有0人评价)
购买数量:
+ -
  • 商品名称:553-21-9木香烃内酯
  • 商品毛重:
  • 单位:件
  • 上架时间:2017-11-01 18:26:44

名称: 木香烃内酯英文名称: Costundide分析标准品,>98%产品编号 C115678
CAS号: 553-21-9分子式 C15H20O2分子量232.32
Beilstein号 EC号 MDL号 MFCD00210262PubChem编号

属性

密度 1.0300
溶解性 Soluble in ethanol (50 mM), DMSO (47 mg/ml at 25 °C), and water (
存贮条件 储存温度-20°C

描述

产品介绍 Costunolide is a sesquiterpene lactone isolated from Magnolia sieboldii. The compound is described to act as an antioxidant, anti-mycobacterial, anti-inflammatory, and anti-viral, with cytotoxic activity. Additionally, Costunolide is reported to inhibit the activity of TERT (telomerase). Studies indicate that Costunolide activates JNK downstream of ROS in leukemia cells, and upstream of Bcl-2. The compound has also been suggested to act as an inhibitor of NOS (nitric oxide synthase) and the VEGFR KDR/Flk-1 signaling pathway
别名 ;(3aS,6E,10E,11aR)-6,10-Dimethyl-3-methylidene-3a,4,5,8,9,11a-hexahydrocyclodeca[d]furan-2-one
生化机理

Description:
IC50 Value: 6.2 - 9.8 ?g/mL(sarcoma cells viability)[3]
Costunolide, a sesquiterpene lactone, exhibits anti-inflammatory and anti-oxidant properties and mediates apoptosis.
in vitro: Costunolide significantly inhibited RANKL-induced BMM differentiation into osteoclasts in a dose-dependent manner without affecting cytotoxicity. Costunolide did not regulate the early signaling pathways of RANKL, including the mitogen-activated protein kinase and NF-κB pathways. However, costunolide suppressed nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) expression via inhibition of c-Fos transcriptional activity without affecting RANKL-induced c-Fos expression. The inhibitory effects ofcostunolide were rescued by overexpression of constitutively active (CA)-NFATc1 [1]. Exposure of T24 cells to costunolide was also associated with increased expression of Bax, down-regulation of Bcl-2, survivin and significant activation of caspase-3, and it

应用 A sequiterpene lactone that inhibits telomerase

购买人 出价 数量 购买时间 状态
我要咨询 购买前咨询(共0记录)
我要提讨论
  • 讨论内容

  • 验证码

  •  
返回顶部